A Two-Part, Randomized, Open-label, Multicenter, Phase 2a/2b Study of the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared to Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemia Vera (KRT-232-102)
- Perkins, Andrew (Primary Chief Investigator (PCI))
- Burbury, Kate L (Chief Investigator (CI))
- Kennedy, Nola (Project Manager)
Project: Research